Business, A.I. and the future of tech: a conversation with PredictMedix’s (PMED.V) Kapil Raval

Small caps in Canada, especially in tech, are full of faux-companies. You know,
the kind where the problem being solved isn’t really a problem, and the
“technology” being advertised is actually five years old.

PredictMedix (PMED.C) isn’t one of them.

The last time I wrote about PredictMedix, I made an argument about:

1. The resilience of pharmaceuticals as a sector, and
2. The scalability of the tech, and hence the business

Since then, the stock has been pumped. Listen in as Arth talks with Kapil Raval!